Circulating Tumor Cells in Solid Tumors

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

206 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-12-09

Study Completion Date

2021-02-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to identify circulating tumor cells in patients with solid tumors. Quantify and characterize these cells, collect patient information in regards to the patient's cancer. Develop a database and a sample repository where future analysis could be done.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Culture of Circulating Tumor Cells Isolated From Cancer Patients With Metastatic Disease

NCT02781025

Circulating Tumor Cells

COMPLETED

Circulating Tumor Cells (CTC) in Cancer

NCT04520672

Cancer

RECRUITING

Collection of Blood From Patients With Cancer

NCT00034216

Prostate Cancer Breast Cancer Colon Cancer +2 more

RECRUITING

Culture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other Cancers

NCT01528774

Melanoma

COMPLETED

Detection of Circulating Tumor Cells in Peripheral Blood From Healthy Volunteers and Patients With Cancer

NCT02904161

Circulating Tumor Cells (CTCs)

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary purpose of this correlative study is to create a prospective database documenting the quantity and characterization of circulating tumor cells (CTCs) in solid tumor patients as identified by a various laboratory techniques and analyses. The investigators are developing this resource to provide data to achieve the following objectives: 1) correlate CTCs with known prognostic factors, 2) correlate CTCs with burden of disease, 3) evaluate the ability of CTCs to be used in the surveillance of disease recurrence, and 4) evaluate CTCs ability to be used as a biomarker for treatment response.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Solid Tumor, Adult

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Observational

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years of age
* Biopsy proven solid tumor malignancy
* Seen at UNC Chapel Hill Hospital and Health Care System
* Consents to abstraction of their medical records
* Signed an institutional review board (IRB)-approved informed consent document for this protocol

Exclusion Criteria

* \< 18 years of age
* Dementia, altered mental status, incarceration or any psychiatric condition that would prohibit the understanding or rendering of informed consent.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No